Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

Parkinson’s is a progressive neurological condition driven by the loss of dopamine-producing neurons, which causes tremors, ...

Adult stem cells can be altered to have the ... There’s no FDA-approved stem cell therapy for Parkinson’s, but clinical ...

Techniques that cause multipotent adult mesenchymal stem cells (MSCs) to differentiate ... activities in the OA joint. Targeted gene therapy might further enhance these activities of MSCs.

Cord blood transplants—considered an adult stem cell therapy because the cells come from infants, not embryos—have been performed since 1988. Like bone marrow, which doctors have been ...

Using modified mRNA technology—the same technology used to develop COVID-19 vaccines—the researchers successfully "awakened" the adult stem cells, allowing them to divide in a controlled ...

The stem cell treatment involved the injection of roughly two million reprogrammed or induced pluripotent stem (iPS) cells, which are created by hacking adult cells back into an embryonic-like state.